{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T15:22:23Z","timestamp":1783351343838,"version":"3.54.6"},"reference-count":16,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["aacejournalendocrinepractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Endocrine Practice"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1016\/j.eprac.2024.11.001","type":"journal-article","created":{"date-parts":[[2024,11,9]],"date-time":"2024-11-09T10:14:35Z","timestamp":1731147275000},"page":"176-179","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Nasolacrimal Duct Obstruction Following Radioactive Iodine: An Update on Counseling Recommendations for Thyroid Cancer Survivors"],"prefix":"10.1016","volume":"31","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1671-4377","authenticated-orcid":false,"given":"Natalie A.","family":"Homer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaniksha","family":"Desai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.eprac.2024.11.001_bib1","doi-asserted-by":"crossref","first-page":"285","DOI":"10.2214\/AJR.19.22626","article-title":"Radioactive iodine therapy in differentiated thyroid cancer: 2020 update","volume":"215","author":"Ciarallo","year":"2020","journal-title":"AJR Am J Roentgenol"},{"issue":"4","key":"10.1016\/j.eprac.2024.11.001_bib2","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1097\/IOP.0000000000000647","article-title":"Iodine-131 therapy and nasolacrimal duct obstructions: what we know and what we need to know","volume":"32","author":"Ali","year":"2016","journal-title":"Ophthal Plast Reconstr Surg"},{"key":"10.1016\/j.eprac.2024.11.001_bib3","first-page":"2479","article-title":"Nasolacrimal duct obstruction following radioactive iodine 131 therapy in differentiated thyroid cancers: review of 19 cases","volume":"8","author":"Al-Qahtani","year":"2014","journal-title":"Clin Ophthalmol"},{"issue":"5","key":"10.1016\/j.eprac.2024.11.001_bib4","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1097\/01.iop.0000179369.75569.a8","article-title":"Expression of sodium iodide symporter in the lacrimal drainage system: implication for the mechanism underlying nasolacrimal duct obstruction in I(131)-treated patients","volume":"21","author":"Morgenstern","year":"2005","journal-title":"Ophthal Plast Reconstr Surg"},{"key":"10.1016\/j.eprac.2024.11.001_bib5","first-page":"1452","article-title":"Radioiodine secretion in tears","volume":"39","author":"Bakheet","year":"1998","journal-title":"J\u00a0Nucl Med"},{"issue":"3","key":"10.1016\/j.eprac.2024.11.001_bib6","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1097\/SCS.0000000000006108","article-title":"Relationship between primary acquired nasolacrimal duct obstruction, paranasal abnormalities and nasal septal deviation","volume":"31","author":"Dikici","year":"2020","journal-title":"J\u00a0Craniofac Surg"},{"issue":"5","key":"10.1016\/j.eprac.2024.11.001_bib7","doi-asserted-by":"crossref","first-page":"226","DOI":"10.3109\/01676830.2011.584931","article-title":"Facial asymmetry and nasal septal deviation in acquired nasolacrimal duct obstruction","volume":"30","author":"Taban","year":"2011","journal-title":"Orbit"},{"issue":"1","key":"10.1016\/j.eprac.2024.11.001_bib8","doi-asserted-by":"crossref","first-page":"21","DOI":"10.5152\/eurasianjmed.2019.19034","article-title":"Sinonasal anatomical variations and primary acquired nasolacrimal duct obstruction: a single centre, case-control investigation","volume":"52","author":"Samarei","year":"2020","journal-title":"Eurasian J Med"},{"issue":"12","key":"10.1016\/j.eprac.2024.11.001_bib9","doi-asserted-by":"crossref","first-page":"5817","DOI":"10.1210\/jc.2002-020210","article-title":"Nasolacrimal drainage system obstruction from radioactive iodine therapy for thyroid carcinoma","volume":"87","author":"Kloos","year":"2002","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.eprac.2024.11.001_bib10","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1097\/IOP.0000000000000603","article-title":"Iodine-131 therapy and lacrimal drainage system toxicity: nasal localization studies using whole body nuclear scintigraphy and SPECT CT","volume":"33","author":"Ali","year":"2017","journal-title":"Ophthal Plast Reconstr Surg"},{"issue":"12","key":"10.1016\/j.eprac.2024.11.001_bib11","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1016\/j.eprac.2022.08.006","article-title":"Factors associated with radioactive iodine therapy-acquired nasolacrimal duct obstruction","volume":"28","author":"Lee","year":"2022","journal-title":"Endocr Pract"},{"key":"10.1016\/j.eprac.2024.11.001_bib12","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1002\/cncr.11527","article-title":"Blockage of the lacrimal drainage apparatus as a side effect of docetaxel therapy","volume":"98","author":"Esmaeli","year":"2023","journal-title":"Cancer"},{"issue":"4","key":"10.1016\/j.eprac.2024.11.001_bib13","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1097\/00007691-200108000-00002","article-title":"Perchlorate clinical pharmacology and human health: a review","volume":"23","author":"Soldin","year":"2001","journal-title":"Ther Drug Monit"},{"issue":"1","key":"10.1016\/j.eprac.2024.11.001_bib14","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1089\/thy.2023.0338","article-title":"A\u00a0pilot nonrandomized controlled trial examining the use of artificial tears on the radioactivity of tears after radioactive iodine treatment for thyroid cancer","volume":"34","author":"Lee","year":"2024","journal-title":"Thyroid"},{"key":"10.1016\/j.eprac.2024.11.001_bib15","first-page":"533","article-title":"Effect of perchlorate on the human thyroid gland","volume":"1","author":"Stanbury","year":"1952","journal-title":"Metab Clin Exp"},{"issue":"2","key":"10.1016\/j.eprac.2024.11.001_bib16","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1097\/IOP.0000000000002542","article-title":"Topical application of perchlorate: a toxicity study in rats","volume":"40","author":"Ulloa-Padilla","year":"2024","journal-title":"Ophthal Plast Reconstr Surg"}],"container-title":["Endocrine Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X24008255?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X24008255?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,26]],"date-time":"2025-02-26T23:21:06Z","timestamp":1740612066000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1530891X24008255"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":16,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,2]]}},"alternative-id":["S1530891X24008255"],"URL":"https:\/\/doi.org\/10.1016\/j.eprac.2024.11.001","relation":{},"ISSN":["1530-891X"],"issn-type":[{"value":"1530-891X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Nasolacrimal Duct Obstruction Following Radioactive Iodine: An Update on Counseling Recommendations for Thyroid Cancer Survivors","name":"articletitle","label":"Article Title"},{"value":"Endocrine Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eprac.2024.11.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 AACE. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}